Sex differences in tobacco use among persons living with HIV/AIDS: A systematic review and meta-analysis

Journal of Acquired Immune Deficiency Syndromes

Volumn 74, Issue 4, 2017, Pages 439-453

  Weinberger, Andrea H ^a,b   Smith, Philip H ^c   Funk, Allison P ^d   Rabin, Shayna ^a   Shuter, Jonathan ^b  

^a YESHIVA UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^d HOFSTRA UNIVERSITY   (United States)

Author keywords

HIV AIDS; metaanalysis; review; sex; smoking; tobacco

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDLINE; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; TOBACCO; TOBACCO USE; TREATMENT OUTCOME; ATTITUDE TO HEALTH; PSYCHOLOGY; SMOKING CESSATION; TOBACCO USE DISORDER;

FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; SEX FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 85007207580     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001279     Document Type: Review

References (126)

1. USDHHS. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. WHO. WHO Global Report: Mortality Attributable to Tobacco. Geneva, Switzerland: WHO Press; 2012.
3. Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: A nationwide, populationbased cohort study. Clin Infect Dis. 2013;56:727-734.
4. Park LS, Hernandez-Ramirez RU, Silverberg MJ, et al. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: A metaanalysis. AIDS. 2016;30:273-291.
5. Ande A, McArthur C, Ayuk L, et al. Effect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individuals. PLoS One. 2015;10:e0122402.
6. De P, Farley A, Lindson N, et al. Systematic review and meta-analysis: Influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013;11:15.
7. Calvo M, Laguno M, Martinez M, et al. Effects of tobacco smoking on HIV-infected individuals. AIDS Rev. 2015;17:47-55.
8. Silverberg MJ, Lau B, Achenbach CJ, et al. Cumulative incidence of cancer among persons with HIV in North America: A cohort study. Ann Intern Med. 2015;163:507-518.
9. Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29:221-229.
10. Aliyu MH, Weldeselasse H, August EM, et al. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine Tob Res. 2013;15:177-184.
11. Calvet GA, Grinsztejn BG, Quintana Mde S, et al. Predictors of early menopause in HIV-infected women: A prospective cohort study. Am J Obstet Gynecol. 2015;212:765. e1-765.e13.
12. Suy A, Martinez E, Coll O, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59-66.
13. Vidrine DJ, Arduino RC, Gritz ER. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/ AIDS. AIDS Patient Care STDS. 2007;21:659-666.
14. Benard A, Mercie P, Alioum A, et al. Bacterial pneumonia among HIVinfected patients: Decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS One. 2010;5:e8896.
15. Petoumenos K, Worm S, Reiss P, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D: A:D study. HIV Med. 2011;12:412-421.
16. Jamal A, King BA, Neff LJ, et al. Current cigarette smoking among adults-United States, 2005-2015. MMWR Morb Mortal Wkly Rep. 2016;65:1205-1211.
17. CDC. Tobacco product Use among adults-United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014;63:542-547.
18. Grant BF, Hasin DS, Chou P, et al. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry. 2004;61:1107-1115.
19. Mendelsohn C. Women who smoke: A review of the evidence. Aust Fam Physician. 2010;39:403-407.
20. Smith PH, Kasza K, Hyland A, et al. Gender differences in medication use and cigarette smoking cessation: Results from the International tobacco Control Four country Survey. Nicotine Tob Res. 2015;17:463-472.
21. Bohadana A, Nilsson F, Rasmussen T, et al. Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior. Nicotine Tob Res. 2003;5:111-116.
22. Wetter DW, Kenford SL, Smith SS, et al. Gender differences in smoking cessation. J Consult Clin Psychol. 1999;67:555-562.
23. Weinberger AH, Pilver CE, Mazure CM, et al. Stability of smoking status in the U.S. population: A longitudinal investigation. Addiction. 2014;109:1541-1553.
24. Jarvis MJ, Cohen JE, Delnevo CD, et al. Dispelling myths about gender differences in smoking cessation: Population data from the USA, Canada, and Britain. Tob Control. 2013;22:356-360.
25. Mikkelsen SS, Dalum P, Skov-Ettrup LS, et al. What characterises smokers who quit without using help? A study of users and non-users of cessation support among successful ex-smokers. Tob Control. 2015;24:556-561.
26. Weinberger AH, Smith PH, Kaufman M, et al. Consideration of sex in clinical trials of transdermal nicotine patch: A systematic review. Exp Clin Psychopharmacol. 2014;22:373-383.
27. Perkins KA, Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res. 2008;10:1245-1251.
28. Smith PH, Weinberger AH, Zhang J, et al. Sex differences in smoking cessation pharmacotherapy comparative efficacy: A network metaanalysis. Nicotine Tob Res. 2016. doi: 10.1093/ntr/ntw144.
29. Benowitz NL, Lessov-Schlaggar CN, Swan GE, et al. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther. 2006;79:480-488.
30. Leventhal AM, Walters AJ, Boyd S, et al. Gender differences in acute tobacco withdrawal: Effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol. 2007;15:21-36.
31. Pang RD, Leventhal AM. Sex differences in negative affect and lapse behavior during active tobacco abstinence: A laboratory study. Exp Clin Psychopharmacol. 2013;21:269-276.
32. Piasecki TM, Jorenby DE, Smith SS, et al. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol. 2003;11:276-285.
33. McKee SA, O'Malley SS, Salovey P, et al. Perceived risks and benefits of smoking cessation: Gender-specific predictors of motivation and treatment outcome. Addict Behav. 2005;30:423-435.
34. Vidrine DJ. Cigarette smoking and HIV/AIDS: Health implications, smoker characteristics, and cessation strategies. AIDS Educ Prev. 2009; 21(suppl A):3-13.
35. Webb MS, Vanable PA, Carey MP, et al. Cigarette smoking among HIV+ men and women: Examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30:371-383.
36. Collins RL, Kanouse DE, Gifford AL, et al. Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample. Health Psychol. 2001;20:351-360.
37. Turner J, Page-Shafer K, Chin DP, et al. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS. 2001;15:615-624.
38. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16:39-42.
39. Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6:71-77.
40. Neumann T, Woiwod T, Neumann A, et al. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: Gender differences. Eur J Med Res. 2004;9:55-60.
41. Miguez-Burbano MJ, Ashkin D, Rodriguez A, et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis. 2005;9:208-217.
42. Benard A, Tessier JF, Rambeloarisoa J, et al. HIV infection and tobacco smoking behaviour: Prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis. 2006;10:378-383.
43. Elzi L, Spoerl D, Voggensperger J, et al. A smoking cessation programme in HIV-infected individuals: A pilot study. Antivir Ther. 2006;11:787-795.
44. Glass TR, Ungsedhapand C, Wolbers M, et al. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: The Swiss HIV Cohort Study. HIV Med. 2006;7:404-410.
45. Mbulaiteye SM, Atkinson JO, Whitby D, et al. Risk factors for human herpes virus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol. 2006;35:442-449.
46. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: Toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS. 2007;21:458-468.
47. Carr A, Grund B, Neuhaus J, et al. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS. 2008;22:257-267.
48. De Socio GV, Parruti G, Quirino T, et al. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: Results from the SIMONE study. J Infect. 2008;57:33-40.
49. Duval X, Baron G, Garelik D, et al. Living with HIV, antiretroviral treatment experience and tobacco smoking: Results from a multisite cross-sectional study. Antivir Ther. 2008;13:389-397.
50. Jacobson DL, Spiegelman D, Knox TK, et al. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J Acquir Immune Defic Syndr. 2008;49:298-308.
51. Murdoch DM, Napravnik S, Eron JJ Jr, et al. Smoking and predictors of pneumonia among HIV-infected patients receiving care in the HAART era. Open Respir Med J. 2008;2:22-28.
52. Desalu OO, Oluboyo PO, Olokoba AB, et al. Prevalence and determinants of tobacco smoking among HIV patients in North Eastern Nigeria. Afr J Med Med Sci. 2009;38:103-108.
53. Jaquet A, Ekouevi DK, Aboubakrine M, et al. Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries. Int J Tuberc Lung Dis. 2009;13:1433-1439.
54. Peretti-Watel P, Garelik D, Baron G, et al. Smoking motivations and quitting motivations among HIV-infected smokers. Antivir Ther. 2009;14:781-787.
55. Webb MS, Vanable PA, Carey MP, et al. Medication adherence in HIVinfected smokers: The mediating role of depressive symptoms. AIDS Educ Prev. 2009;21(suppl 3):94-105.
56. Aboud M, Elgalib A, Pomeroy L, et al. Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: Implications for clinical management: The CREATE 1 study. Int J Clin Pract. 2010;64:1252-1259.
57. Cahn P, Leite O, Rosales A, et al. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART. Braz J Infect Dis. 2010;14:158-166.
58. Cui Q, Carruthers S, McIvor A, et al. Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIVpositive subjects: A cross-sectional study. AIDS Res Ther. 2010;7:6.
59. Encrenaz G, Benard A, Rondeau V, et al. Determinants of smoking cessation attempts among HIV-infected patients results from a hospitalbased prospective cohort. Curr HIV Res. 2010;8:212-217.
60. Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 2010;100:1896-1903.
61. Tesoriero JM, Gieryic SM, Carrascal A, et al. Smoking among HIV positive New Yorkers: Prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824-835.
62. Amiya RM, Poudel KC, Poudel-Tandukar K, et al. Physicians are a key to encouraging cessation of smoking among people living with HIV/ AIDS: A cross-sectional study in the Kathmandu Valley, Nepal. BMC Public Health. 2011;11:677.
63. Brion JM, Rose CD, Nicholas PK, et al. Unhealthy substance-use behaviors as symptom-related self-care in persons with HIV/AIDS. Nurs Health Sci. 2011;13:16-26.
64. Collazos J, Carton JA, Asensi V. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus. Curr HIV Res. 2011;9:339-345.
65. Pines H, Koutsky L, Buskin S. Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008). AIDS Beh. 2011;15:243-251.
66. Shapiro AE, Tshabangu N, Golub JE, et al. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. Int J Tuberc Lung Dis. 2011;15:140-142.
67. Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behav Med. 2011;37: 77-80.
68. Beachler DC, Weber KM, Margolick JB, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev. 2012; 21:122-133.
69. Chander G, Stanton C, Hutton HE, et al. Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS Beh. 2012;16:383-388.
70. Kristoffersen US, Lebech A-M, Mortensen J, et al. Changes in lung function of HIV-infected patients: A 4.5-year follow-up study. Clin Physiol Funct Imaging 2012;32:288-295.
71. Iliyasu Z, Gajida AU, Abubakar IS, et al. Patterns and predictors of cigarette smoking among HIV-infected patients in northern Nigeria. Int J STD AIDS. 2012;23:849-852.
72. Moadel AB, Bernstein SL, Mermelstein RJ, et al. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61: 208-215.
73. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36:75-85.
74. Villanti A, German D, Sifakis F, et al. Smoking, HIV status, and HIV risk behaviors in a respondent-driven sample of injection drug users in Baltimore, Maryland: The BeSure Study. AIDS Educ Prev. 2012;24:132-147.
75. Batista Jd, Militao de AlbuquerqueMde F, Ximenes RA, et al. Prevalence and socioeconomic factors associated with smoking in people living with HIV by sex, in Recife. Brazil Rev Bras Epidemiol. 2013;16:432-443.
76. Bryant VE, Kahler CW, Devlin KN, et al. The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care. 2013;25:1308-1316.
77. Buchacz K, Baker RK, Palella FJ Jr, et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther. 2013;18:65-75.
78. Cropsey KL, Hendricks PS, Jardin B, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38:2541-2546.
79. Shirley DK, Kesari RK, Glesby MJ. Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDS. 2013;27:604-612.
80. Siconolfi DE, Halkitis PN, Barton SC, et al. Psychosocial and demographic correlates of drug use in a sample of HIV-positive adults ages 50 and older. Prev Sci. 2013;14:618-627.
81. Tami-Maury I, Vidrine DJ, Fletcher FE, et al. Poly-tobacco use among HIV-positive smokers: Implications for smoking cessation efforts. Nicotine Tob Res. 2013;15:2100-2106.
82. Waweru P, Anderson R, Steel H, et al. The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa. S Afr Med J. 2013;103:858-860.
83. Aichelburg MC, Mandorfer M, Tittes J, et al. The association of smoking with IGRA and TST results in HIV-1-infected subjects. Int J Tuberc Lung Dis. 2014;18:709-716.
84. Chew D, Steinberg MB, Thomas P, et al. Evaluation of a smoking cessation program for HIV infected individuals in an urban HIV clinic: Challenges and lessons learned. AIDS Res Treat. 2014;2014:237834.
85. Luo X, Duan S, Duan Q, et al. Tobacco use among HIV-infected individuals in a rural community in Yunnan Province, China. Drug Alcohol Depend. 2014;134:144-150.
86. Miguez-Burbano MJ, Vargas M, Quiros C, et al. Menthol cigarettes and the cardiovascular risks of people living with HIV. J Assoc Nurses AIDS Care 2014;25:427-435.
87. Pacek LR, Latkin C, Crum RM, et al. Current cigarette smoking among HIV-positive current and former drug users: Associations with individual and social characteristics. AIDS Beh. 2014;18:1368-1377.
88. Pacek LR, Latkin C, Crum RM, et al. Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug Alcohol Depend. 2014;138:220-224.
89. Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23:582-590.
90. Shuter J, Moadel AB, Kim RS, et al. Self-efficacy to quit in HIV-infected smokers. Nicotine Tob Res. 2014;16:1527-1531.
91. Shuter J, Morales D, Considine-Dunn S, et al. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV infected smokers: A randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67:59-66.
92. Samperiz G, Guerrero D, Lopez M, et al. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med. 2014;15:321-329.
93. Torres TS, Luz PM, Derrico M, et al. Factors associated with tobacco smoking and cessation among HIV-infected individuals under care in Rio de Janeiro, Brazil. PLoS One. 2014;9:e115900.
94. Tron L, Lert F, Spire B, et al. Tobacco smoking in HIV-infected versus general population in France: Heterogeneity across the various groups of people living with HIV. PLoS One. 2014;9:e107451.
95. Vijayaraghavan M, Penko J, Vittinghoff E, et al. Smoking behaviors in a community-based cohort of HIV-infected indigent adults. AIDS Behav. 2014;18:535-543.
96. Ahlstrom MG, Feldt-Rasmussen B, Legarth R, et al. Smoking and renal function in people living with human immunodeficiency virus: A Danish nationwide cohort study. Clin Epidemiol. 2015;7:391-399.
97. Cioe PA, Baker J, Kojic EM, et al. Elevated soluble CD14 and lower d-dimer are associated with cigarette smoking and heavy episodic alcohol use in persons living with HIV. J Acquir Immune Defic Syndr. 2015;70:400-405.
98. Estrada V, Bernardino JI, Masia M, et al. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain. HIV Clin Trials. 2015;16:57-65.
99. Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: Cross-sectional surveys. Ann Intern Med. 2015;162: 335-344.
100. Moreno JL, Catley D, Lee HS, et al. The relationship between ART adherence and smoking status among HIV+ individuals. AIDS Behav. 2015; 19:619-625.
101. Nguyen NP, Tran BX, Hwang LY, et al. Prevalence of cigarette smoking and associated factors in a large sample of HIV-positive patients receiving antiretroviral therapy in Vietnam. PLoS One. 2015;10:e0118185.
102. O'Cleirigh C, Valentine SE, Pinkston M, et al. The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use. AIDS Behav. 2015;19:178-185.
103. Rasmussen LD, Helleberg M, May MT, et al. Myocardial infarction among Danish HIV-infected individuals: Population-attributable fractions associated with smoking. Clin Infect Dis. 2015;60:1415-1423.
104. Schäfer J, Young J, Bernasconi E, et al. Predicting smoking cessation and its relapse in HIV-infected patients: The Swiss HIV Cohort Study. HIV Med. 2015;16:3-14.
105. Shelley D, Tseng TY, Gonzalez M, et al. Correlates of adherence to varenicline among HIV+ smokers. Nicotine Tob Res. 2015;17:968-974.
106. Zyambo CM, Willig JH, Cropsey KL, et al. Factors associated with smolking status among HIV-positive patients in routine clinical care. J AIDS Clin Res. 2015;6:7.
107. Browning KK, Wewers ME, Ferketich AK, et al. Adherence to tobacco dependence treatment among HIV-infected smokers. AIDS Behav. 2016; 20:608-621.
108. de Dios MA, Stanton CA, Cano MÁ, et al. The influence of social support on smoking cessation treatment adherence among HIV+ smokers. Nicotine Tob Res. 2016;18:1126-1133.
109. Marando F, Gualberti G, Costanzo AM, et al. Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment: The DHIVA study. AIDS Care. 2016;28:147-159.
110. Muyanja D, Muzoora C, Muyingo A, et al. High prevalence of metabolic syndrome and cardiovascular disease risk among people with HIV on stable ART in southwestern Uganda. AIDS Patient Care STDS. 2016;30:4-10.
111. Shuter J, Pearlman BK, Stanton CA, et al. Gender differences among smokers living with HIV. J Int Assoc Provid AIDS Care. 2016;15: 412-417.
112. Wang Y, Chen X, Li X, et al. Cigarette smoking among Chinese PLWHA: An exploration of changes in smoking after being tested HIV positive. AIDS Care. 2016;28:365-369.
113. Wolfgang V. Conducting meta-analyses in R with the Metafor package. J Stat Softw. 2010;36:1-48.
114. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
115. Parhami I, Fong TW, Siani A, et al. Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California. AIDS Behav. 2013;17:2792-2801.
116. Pence BW, Miller WC, Whetten K, et al. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42:298-306.
117. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23:e147-e53.
118. Weinberger AH, Funk AP, Goodwin RD. A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders. Prev Med. 2016;92:148-159.
119. Shiffman S, Brockwell SE, Pillitteri JL, et al. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34:102-111.
120. CDC. Quitting smoking among adults-United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011;60:1513-1519.
121. McMillen RC, Gottlieb MA, Whitmore Shaefer RM, et al. Trends in electronic cigarette use among U.S. adults: Use is increasing in both smokers and nonsmokers. Nicotine Tob Res. 2015;17:1195-1202.
122. Ledgerwood DM, Yskes R. Smoking cessation for people living with HIV/AIDS: A literature review and synthesis. Nicotine Tob Res. 2016; 18:2177-2184.
123. Nahvi S, Cooperman NA. Review: The need for smoking cessation among HIV-positive smokers. AIDS Educ Prev. 2009;21(suppl A):14-27.
124. Moscou-Jackson G, Commodore-Mensah Y, Farley J, et al. Smokingcessation interventions in people living with HIV infection: A systematic review. J Assoc Nurses AIDS Care. 2014;25:32-45.
125. Pool ERM, Dogar O, Lindsay RP, et al. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016; Issue 6. Art. No.: CD011120.
126. Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26:196-215.